Trump threatens Aussie medicines with bitter tax pill

Donald Trump has given alarms to one of the largest US exports of Australia, alarms, but many asks for many of them.
The US President organized plans to bring 200 percent tariffs to drug imports within a year and threatened the third most important export to the United States as Australia expanded the trade war.
Trump’s proposal comes after lobbying by the powerful US pharmaceutical industry, which has long been able to take problems with Australia’s drug subsidies plan and wants the president to take action.
His announcement can be seen as a way of disintegration of the US in the pharmaceutical benefits program in exchange for a trade agreement.
However, according to Australia, the pharmaceutical industry Body Medicines, the lack of details about Mr. Trump wondered how many would look.
“Hearing these numbers is quite worrying, but we don’t know what’s going to happen in reality, El Elizabeth de Somer AAP said.
“The messaging from the US administration shows an intention, but we have seen that these intentions have changed quite quickly.”
Wesley Widmaier, Australian National University International Relations Specialist, said that the US pharmaceutical industry has spent decades to try to improve the profits of the Pharmaceutical industry, and these intentions play an important role in American policy.
For example, in 2004, after the Australian-US Free Trade Agreement negotiations, the United States provided a great privilege to provide more consultation in the PBS.
Professor Widmaier AAP told him that “American companies with patents – giving them a monopoly – it was always a source of concern for this monopoly to enjoy as long as possible,” he said.

“Trump certainly brings this kind of dynamic base.
“But we shouldn’t assume that this is something outside the limits of understanding America’s national interests.”
Prof Widmaier also had doubts about whether 200 percent tariff would be realized.
Even at the schedule for taste with China, the US Levies reached 145 percent.
“It looks like an embargo on two hundred percent percentage,” he said.
Ms. Somer believes that drugs do not support Australia’s US colleagues’ drug tariffs.
Instead, they prefer improvements in the scheme of Australia, because it takes too long, did not keep up with new technology and does not appropriately recognize and value innovations to support patients.
Treasurer Jim Chalmers, while continuing tariff negotiations with Australia USA, claimed that PBS “is nothing we want to trade or agree.”

Drugs supported the Australian government’s efforts to strengthen the plan.
Mr. Trump also announced a 50 percent tariff on copper imported to the United States, but this creates little problems for Australia because the US constitutes less than one percent of the country’s metal exports.
Compared, Australia sent medical and medicine of $ 2.1 billion to the US in 2024.
The words of the President are the last of a series of new trade measures after explaining a 25 percent tariff from Japan and Korea, the second and third largest export markets of Australia.
Some countries have tried to make trade agreements with the United States, and Prime Minister Anthony Albania faced increasing pressure to plan a face -to -face meeting with Mr. Trump.
However, it was not clear whether this would work.
“Now we are in a situation where the US is trying to negotiate 100 trade agreements at the same time – this is beyond the capacity of American negotiators,” he said.

Australian Associated Press is a beating heart of Australian news. AAP has been the only independent national Newswire of Australia and has been providing reliable and fast news content to the media industry, the government and the corporate sector for 85 years. We inform Australia.




